Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 3
2008 4
2009 7
2010 12
2011 11
2012 6
2013 4
2014 3
2015 7
2016 8
2017 14
2018 24
2019 48
2020 58
2021 107
2022 51
2023 45
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

368 results

Results by year

Filters applied: . Clear all
Page 1
Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus.
Yaribeygi H, Sathyapalan T, Atkin SL, Sahebkar A. Yaribeygi H, et al. Among authors: sathyapalan t. Oxid Med Cell Longev. 2020 Mar 9;2020:8609213. doi: 10.1155/2020/8609213. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32215179 Free PMC article. Review.
The Effect of Combined Vitamin C and Vitamin E Supplementation on Oxidative Stress Markers in Women with Endometriosis: A Randomized, Triple-Blind Placebo-Controlled Clinical Trial.
Amini L, Chekini R, Nateghi MR, Haghani H, Jamialahmadi T, Sathyapalan T, Sahebkar A. Amini L, et al. Among authors: sathyapalan t. Pain Res Manag. 2021 May 26;2021:5529741. doi: 10.1155/2021/5529741. eCollection 2021. Pain Res Manag. 2021. PMID: 34122682 Free PMC article. Clinical Trial.
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial.
Mosenzon O, Blicher TM, Rosenlund S, Eriksson JW, Heller S, Hels OH, Pratley R, Sathyapalan T, Desouza C; PIONEER 5 Investigators. Mosenzon O, et al. Among authors: sathyapalan t. Lancet Diabetes Endocrinol. 2019 Jul;7(7):515-527. doi: 10.1016/S2213-8587(19)30192-5. Epub 2019 Jun 9. Lancet Diabetes Endocrinol. 2019. PMID: 31189517 Free article. Clinical Trial.
Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial.
Ajjan RA, Heller SR, Everett CC, Vargas-Palacios A, Higham R, Sharples L, Gorog DA, Rogers A, Reynolds C, Fernandez C, Rodrigues P, Sathyapalan T, Storey RF, Stocken DD. Ajjan RA, et al. Among authors: sathyapalan t. Diabetes Care. 2023 Feb 1;46(2):441-449. doi: 10.2337/dc22-1219. Diabetes Care. 2023. PMID: 36516054 Free PMC article. Clinical Trial.
Etiopathogenesis of Psoriasis from Genetic Perspective: An updated Review.
Babaie F, Omraninava M, Gorabi AM, Khosrojerdi A, Aslani S, Yazdchi A, Torkamandi S, Mikaeili H, Sathyapalan T, Sahebkar A. Babaie F, et al. Among authors: sathyapalan t. Curr Genomics. 2022 Jul 5;23(3):163-174. doi: 10.2174/1389202923666220527111037. Curr Genomics. 2022. PMID: 36777004 Free PMC article. Review.
Harnessing CRISPR/Cas9 technology in cardiovascular disease.
Rezaei H, Khadempar S, Farahani N, Hosseingholi EZ, Hayat SMG, Sathyapalan T, Sahebkar AH. Rezaei H, et al. Among authors: sathyapalan t. Trends Cardiovasc Med. 2020 Feb;30(2):93-101. doi: 10.1016/j.tcm.2019.03.005. Epub 2019 Mar 26. Trends Cardiovasc Med. 2020. PMID: 30935726 Review.
Naturally Occurring SGLT2 Inhibitors: A Review.
Yaribeygi H, Ashrafizadeh M, Sathyapalan T, Jamialahmadi T, Sahebkar A. Yaribeygi H, et al. Among authors: sathyapalan t. Adv Exp Med Biol. 2021;1328:523-530. doi: 10.1007/978-3-030-73234-9_37. Adv Exp Med Biol. 2021. PMID: 34981503 Review.
368 results